Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis
- 1 January 1998
- journal article
- Published by Elsevier in Tubercle and Lung Disease
- Vol. 78 (2) , 117-122
- https://doi.org/10.1016/s0962-8479(98)80004-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The action of antituberculosis drugs in short-course chemotherapyPublished by Elsevier ,2004
- Drug-Resistant Tuberculosis: Review of the Worldwide Situation and the WHO/IUATLD Global Surveillance ProjectClinical Infectious Diseases, 1997
- Selection of a gyrA Mutant of Mycobacterium tuberculosis Resistant to Fluoroquinolones during Treatment with OfloxacinThe Journal of Infectious Diseases, 1994
- inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosisScience, 1994
- The rpsL gene and streptomycin resistance in single and multiple drug‐resistant strains of Mycobacterium tuberculosisMolecular Microbiology, 1993
- Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknotMolecular Microbiology, 1993
- Detection of rifampicin-resistance mutations in Mycobacterium tuberculosisThe Lancet, 1993
- The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosisNature, 1992
- Tuberculosis in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- Pyrazinamidase activity of Mycobacterium tuberculosis—A test of sensitivity to pyrazinamideTubercle, 1987